- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05725278
Impact Evaluation of Triggerise's Tiko Platform
Health Impact Evaluation of Triggerise's Tiko Platform
Triggerise designed web and phone based Tiko platform to connect young girls and women to the health products, services and information. The platform uses principles of behaviour economics to motivate positive choices-including rewards, promotions, discounts, coupons, reminders, alerts etc. The platform was implemented in several cities from seven states of India to provide Sexual Reproductive Health (SRH) and maternal and child health (MCH) products and services. The consumers (called Rafikis) use Tiko card to get discounts and to earn 'Tiko miles' rewards at Tiko franchised healthcare providers and pharmacies. Tiko miles are redeemable towards lifestyle products or services (e.g., beauty salons). The local Tiko health promoter (celled Pro agent) can also buy health and hygiene products at bulk discounts and sell them at profit.
Triggerise appointed Network for Engineering, Economics Research and Management (NEERMAN) to conduct an independent impact assessment of the Tiko platform with multiple research objectives include health impact evaluation at the Rafiki level.
NEERMAN used an ex-post observational design to compare usage of SRH and MCH services and family planning (FP), antenatal care (ANC) and postnatal care (PNC) practices by comparing Users and Non-Users of Tiko platform, and accounting for the selection bias statistically. The structured questionnaire collected data on knowledge, practices, barriers, enablers for SRH and MCH services, exposure o Tiko platform, and how it helped or did not help. The survey participants were approx. 1200 users and 600 non-users being served by approx. 350 pro-agents in their respective operations area.
The association between use of Tiko platform and various outcomes were identified using a generalized linear model with fixed effects at pro-agent level and including a set of covariates. To evaluate the effect modification by type of pro agent - government community health worker (CHW) versus others - an interaction model was used. The standard errors were automatically clustered at pro-agent level due to fixed effects. Primary outcomes are proportion of married Rafikis currently using any contraceptives, currently using modern short-term contraceptives, proportion of Rafikis who delivered a child post Jan 2019 and received at least 4 ANC check-ups, consumed at least 100 iron folic acid (IFA( during pregnancy, and received a PNC check-up within 6 weeks of birth.
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maharashtra
-
Mumbai, Maharashtra, India, 400014
- NEERMAN
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women who are registered on Tiko Platform with Pro-agents active in 2020-21
- Age 18-50
- Address and contacts details are found with help of Pro-agent
Exclusion Criteria:
- Does not consent to participation
- Does not agree or confirm registering on Tiko Platform
- If a woman is never married, she is excluded from survey on family planning but surveyed for use of Tiko platform
- If a married woman does not have a child born on/after 1 January 2019, then she is excluded from the survey on antenatal care, delivery and postnatal care but surveyed for use of Tiko platform
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Users of Tiko Platform
These participants accessed various services on Tiko platform such as buying contraceptives, visiting doctors for ANC etc.
They earned Tiko Miles/Points for such health seeking behaviours which they could then redeem at network of grocery shops, pharmacies, beauty salon etc. Tiko card also enabled them to get discounts at pharmacies and at health care providers.
These participants were free to access any other government or private health care facility as free economic agents.
Users of Tiko platform were identified by the backend system that recorded all health seeking behaviours / actions, reward point accumulation, and use of those reward points.
|
Tiko platform is a mix of social franchising and social marketing concepts to promote health behaviours through rewards to health promoters (pro agents), healthcare providers (doctors and pharmacies), Beneficiaries (women needing FP and/or ANC services), and shop keepers and life-style service providers where beneficiaries, providers and promoters could use their rewards points.
The health promoters could purchase from wholesale retailers products such as sanitary napkins, condoms and then resale these at profit.
Beneficiaries were given discounts and their rewards points can be used as cash to avail certain lifestyle services at participating locations, and so did the health care providers.
Pro agents also got incentives for recruiting the beneficiaries and after beneficiaries reached certain service access/use milestones.
All this was integrated on a mHealth platform using smart phones and smart cards (for those without access to Tiko card).
|
ACTIVE_COMPARATOR: Non-Users of Tiko Platform
These participants registered on Tiko platform on basis of recruitment drive and pitch by Pro agents, but they did not access any service and became dormant.
However, These participants were free to access any other government or private health care facility and could access fame family planning and ANC products and services.
They could even access Tiko network doctors and pharmacies but they would not get any Tiko Miles/Points or discounts without the use of Tiko card.
Non Users were identified as those registered women who did not have any record of using services using Tiko card as per the backend system
|
Non-Users of Tiko did not use Tiko platform but they could access any health care provider or pharmacy to avail same services related to Family planning, antenatal care, postnatal care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of women currently using any contraceptives
Time Frame: Through survey completion, an average of 1 month
|
Whether a woman used any contraceptive - traditional or modern methods, and permanent or temporary methods
|
Through survey completion, an average of 1 month
|
Proportion of women currently using modern short-term contraceptives
Time Frame: Through survey completion, an average of 1 month
|
Whether a woman used modern and temporary contraception methods
|
Through survey completion, an average of 1 month
|
Proportion of women who consumed 100 or more Iron Folic Acid (IFA) tablets during last pregnancy
Time Frame: 9 months during pregnancy with the youngest child
|
Whether the study participant recalled consuming 100 or more IFA tablets when pregnant with youngest child born after 1 January 2019
|
9 months during pregnancy with the youngest child
|
Proportion of women who received 4 or more antenatal check-ups during last pregnancy
Time Frame: 9 months during pregnancy with the youngest child
|
Whether the study participant recalled receiving 4 or more ANC check-ups from any health care provider when pregnant with youngest child born after 1 January 2019
|
9 months during pregnancy with the youngest child
|
Proportion of women who received a postnatal check-up within 6 week of the delivery from a healthcare provider
Time Frame: Within 6 weeks after delivery of the youngest child
|
Whether the study participant recalled receiving at least one postnatal health check up within 6 weeks of the youngest child's birth
|
Within 6 weeks after delivery of the youngest child
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Out of pocket expenditure on antenatal care, iron folic acid tablets, delivery, and postnatal check-ups
Time Frame: 9 months during pregnancy with the youngest child
|
Reported expenditure in Indian Rupees for antenatal care, iron folic acid tablets, delivery, and postnatal check-ups associated with the youngest child born after 1 January 2019
|
9 months during pregnancy with the youngest child
|
Out of pocket expenditure on Family planning services and products
Time Frame: Past 24 months (from survey date)
|
Reported expenditure in Indian Rupees for permanent or temporary contraceptive methods
|
Past 24 months (from survey date)
|
Proportion of women receiving Antenatal check-ups at (a) Tiko franchisee doctors, (b) other private doctors, or (c) government healthcare provider
Time Frame: 9 months during pregnancy with the youngest child
|
Separate proportions are estimated for each of the three locations of antenatal check-ups when pregnant with youngest child born after 1 January 2019
|
9 months during pregnancy with the youngest child
|
Proportion of women receiving postnatal check-ups at (a) Tiko franchisee doctors, (b) other private doctors, or (c) government healthcare provider
Time Frame: Within 6 weeks after delivery of the youngest child
|
Separate proportions are estimated for each of the three locations of postnatal check-ups within 6 weeks after delivery of the youngest child born after 1 January 2019
|
Within 6 weeks after delivery of the youngest child
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sumeet Patil, PhD, Network for Engineering and Economics Research and Management
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Triggerise Protocol V2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraception
-
Virginia Commonwealth UniversityCompletedPregnancy Related | Contraception | Contraception Behavior | Contraception Use
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Medical University of South CarolinaSociety of Family PlanningCompletedContraception | Contraception BehaviorUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedFemale Contraception | ContraceptionUnited States, Israel
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
University of California, San FranciscoAgency for Healthcare Research and Quality (AHRQ); Essential Access HealthNot yet recruitingContraception | Contraception Behavior | Reproductive BehaviorUnited States
Clinical Trials on Tiko Platform Behavioural cum mHealth Intervention
-
Ludwig-Maximilians - University of MunichCankado GmbHRecruitingQuality of Life | Nutritional Status | Psychological Distress | Weight Change, BodyGermany